Quadrant Capital Group LLC Taro Pharmaceutical Industries LTD Transaction History

Quadrant Capital Group LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$40.97 - $43.33 $2,171 - $2,296	-53 Reduced 7.16%	687 $29,000
Q4 2023 Feb 08, 2024	BUY	$32.77 - $42.31 $6,717 - $8,673	205 Added 38.32%	740 $30,000
Q3 2023 Nov 14, 2023	BUY	$35.46 - $40.13 $106 - $120	3 Added 0.56%	535 $20,000
Q2 2023 Aug 09, 2023	SELL	$24.24 - $40.97 $16,774 - $28,351	-692 Reduced 56.54%	532 $20,000
Q1 2023 May 11, 2023	BUY	$23.0 - $31.59 $16,238 - $22,302	706 Added 136.29%	1,224 $29,000
Q4 2022 Feb 10, 2023	SELL	$27.6 - $32.99 $20,893 - $24,973	-757 Reduced 59.37%	518 $15,000
Q3 2022 Nov 10, 2022	BUY	$28.74 - $39.9 $22,244 - $30,882	774 Added 154.49%	1,275 $38,000
Q2 2022 Aug 09, 2022	BUY	$35.0 - $43.59 $13,790 - $17,174	394 Added 368.22%	501 $18,000
Q1 2022 May 06, 2022	SELL	$43.12 - $50.3 $22,508 - $26,256	-522 Reduced 82.99%	107 $5,000
Q4 2021 Feb 01, 2022	BUY	$47.6 - $65.0 $23,466 - $32,045	493 Added 362.5%	629 $32,000
Q3 2021 Nov 12, 2021	BUY	$62.34 - $73.38 $2,368 - $2,788	38 Added 38.78%	136 $9,000
Q4 2020 Feb 16, 2021	BUY	$54.4 - $73.42 $2,067 - $2,789	38 Added 63.33%	98 $7,000
Q3 2020 Nov 13, 2020	BUY	$54.41 - $68.2 $3,264 - $4,092	60 New	60 $3,000
Q4 2018 Jan 17, 2019	SELL	$78.25 - $107.92 $4,382 - $6,043	-56 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$95.91 - $107.26 $13,139 - $14,694	-137 Reduced 70.98%	56 $4,000
Q3 2017 Oct 13, 2017	SELL	$97.26 - $116.2 $25,773 - $30,793	-265 Reduced 57.86%	193 $19,000
Q2 2017 Aug 15, 2017	BUY	N/A	458	458 $46,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.